RET and medullary thyroid gland carcinoma: MTC presents as a sporadic (75-80% of cases) (sMTC) or hereditary tumor (hMTC), as part of the multiple endocrine neoplasia 2 syndrome (MEN2) due to a germline REarranged during Transfection (RET) mutation.